Page last updated: 2024-10-19

hydroxide ion and Koch's Disease

hydroxide ion has been researched along with Koch's Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference
" The anti-tuberculosis (anti-TB) drug pyrazinamide (PZA) was successfully intercalated into interlayer galleries of MgLH, resulting in the formation of the nanocomposite, PZA-MgLH, having an average size of about 107 ± 24 nm with a uniform circular shape."8.12Development of a novel anti-tuberculosis nanodelivery formulation using magnesium layered hydroxide as the nanocarrier and pyrazinamide as a model drug. ( Arulselvan, P; Bullo, N; El Zowalaty, ME; Fakurazi, S; Hussein, MZ; Saifullah, B; Webster, TJ, 2022)
" The anti-tuberculosis (anti-TB) drug pyrazinamide (PZA) was successfully intercalated into interlayer galleries of MgLH, resulting in the formation of the nanocomposite, PZA-MgLH, having an average size of about 107 ± 24 nm with a uniform circular shape."4.12Development of a novel anti-tuberculosis nanodelivery formulation using magnesium layered hydroxide as the nanocarrier and pyrazinamide as a model drug. ( Arulselvan, P; Bullo, N; El Zowalaty, ME; Fakurazi, S; Hussein, MZ; Saifullah, B; Webster, TJ, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Saifullah, B1
Arulselvan, P1
Fakurazi, S1
Webster, TJ1
Bullo, N1
Hussein, MZ1
El Zowalaty, ME1

Other Studies

1 other study available for hydroxide ion and Koch's Disease

ArticleYear
Development of a novel anti-tuberculosis nanodelivery formulation using magnesium layered hydroxide as the nanocarrier and pyrazinamide as a model drug.
    Scientific reports, 2022, 08-18, Volume: 12, Issue:1

    Topics: Antitubercular Agents; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hyd

2022